Beneficient (BENF) is a technology-enabled financial services company headquartered in Dallas, Texas. StockAnalysis+2b2idigital.com+2 The firm serves a niche but growing segment: investors in alternative assets — such as private equity, venture capital, real estate, funds, co-investments, and other illiquid vehicles — and offers solutions to provide liquidity or exit options for those assets. Beneficient+1

Replimune Group, Inc. (NASDAQ : REPL) is a clinical-stage biotechnology company headquartered in Woburn, Massachusetts, focused on a novel class of therapies known as oncolytic immunotherapies, developed via its proprietary RPx platform. Replimune+2Replimune+2

Rani Therapeutics is a clinical-stage biopharma company focused on enabling the oral delivery of biologics and drugs. Its signature technology is the RaniPill® capsule (also called RaniPill / robotic pill / RaniPill HC), with the goal of replacing subcutaneous injections or infusions with swallowable capsules. Rani Therapeutics, LLC+3Rani Therapeutics, LLC+3ranitherapeutics.com+3

In the fast-moving world of consumer technology, ideas are plentiful, but defensibility is rare. Anyone can replicate a product’s features, but few companies can build intellectual property (IP) moats that ensure long-term competitive advantage. That’s why some of the world’s most valuable acquisitions have revolved around proprietary technology, not just user growth.

Chesapeake, Va. — [Date] — Greenwave Technology Solutions, Inc. (NASDAQ: GWAV), a company operating in the metal recycling sector, confirmed today that it has implemented a 1-for-110 reverse stock split of its common shares, effective August 22, 2025. The move is intended to boost the per-share price and bring the company back into compliance with Nasdaq’s minimum bid price rule. Quiver Quantitative+1